nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—ADRB1—stomach cancer	0.203	0.366	CbGaD
Propranolol—HTR1A—stomach cancer	0.182	0.327	CbGaD
Propranolol—ADRB2—stomach cancer	0.171	0.307	CbGaD
Propranolol—ABCB1—Mitomycin—stomach cancer	0.0512	0.2	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0269	0.105	CbGbCtD
Propranolol—CYP3A7—Irinotecan—stomach cancer	0.0269	0.105	CbGbCtD
Propranolol—CYP3A5—Irinotecan—stomach cancer	0.0202	0.079	CbGbCtD
Propranolol—CYP3A7—Docetaxel—stomach cancer	0.0197	0.0772	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0197	0.0772	CbGbCtD
Propranolol—CYP3A5—Docetaxel—stomach cancer	0.0148	0.0579	CbGbCtD
Propranolol—CYP1A2—Fluorouracil—stomach cancer	0.0144	0.0564	CbGbCtD
Propranolol—ABCB1—Irinotecan—stomach cancer	0.0131	0.0514	CbGbCtD
Propranolol—ABCB1—Docetaxel—stomach cancer	0.00963	0.0377	CbGbCtD
Propranolol—CYP3A4—Irinotecan—stomach cancer	0.00788	0.0308	CbGbCtD
Propranolol—ABCB1—Doxorubicin—stomach cancer	0.00718	0.0281	CbGbCtD
Propranolol—ABCB1—Methotrexate—stomach cancer	0.00696	0.0272	CbGbCtD
Propranolol—CYP2D6—Doxorubicin—stomach cancer	0.00677	0.0265	CbGbCtD
Propranolol—CYP3A4—Docetaxel—stomach cancer	0.00577	0.0226	CbGbCtD
Propranolol—ORM1—bile—stomach cancer	0.00511	0.204	CbGeAlD
Propranolol—CYP3A4—Doxorubicin—stomach cancer	0.0043	0.0168	CbGbCtD
Propranolol—ORM1—gall bladder—stomach cancer	0.00142	0.0566	CbGeAlD
Propranolol—HTR1B—blood vessel—stomach cancer	0.00141	0.0564	CbGeAlD
Propranolol—ORM1—hematopoietic system—stomach cancer	0.000803	0.032	CbGeAlD
Propranolol—Methocarbamol—CA1—stomach cancer	0.00073	0.0996	CrCbGaD
Propranolol—CYP3A7—endocrine gland—stomach cancer	0.000729	0.0291	CbGeAlD
Propranolol—SLC22A2—digestive system—stomach cancer	0.000724	0.0289	CbGeAlD
Propranolol—CYP3A7—liver—stomach cancer	0.000657	0.0262	CbGeAlD
Propranolol—HTR1A—hematopoietic system—stomach cancer	0.000608	0.0242	CbGeAlD
Propranolol—CYP2C19—hematopoietic system—stomach cancer	0.000567	0.0226	CbGeAlD
Propranolol—CYP3A7-CYP3A51P—liver—stomach cancer	0.000559	0.0223	CbGeAlD
Propranolol—ORM1—bone marrow—stomach cancer	0.000515	0.0205	CbGeAlD
Propranolol—CYP1A2—hematopoietic system—stomach cancer	0.000463	0.0185	CbGeAlD
Propranolol—ORM1—endocrine gland—stomach cancer	0.000461	0.0184	CbGeAlD
Propranolol—CYP1A1—hematopoietic system—stomach cancer	0.000457	0.0182	CbGeAlD
Propranolol—CYP3A5—hematopoietic system—stomach cancer	0.000447	0.0178	CbGeAlD
Propranolol—ABCB1—blood vessel—stomach cancer	0.000446	0.0178	CbGeAlD
Propranolol—HTR1B—endocrine gland—stomach cancer	0.000433	0.0173	CbGeAlD
Propranolol—CYP1A1—epithelium—stomach cancer	0.000418	0.0167	CbGeAlD
Propranolol—ORM1—liver—stomach cancer	0.000416	0.0166	CbGeAlD
Propranolol—ADRB1—endocrine gland—stomach cancer	0.000407	0.0162	CbGeAlD
Propranolol—CYP2C19—digestive system—stomach cancer	0.000394	0.0157	CbGeAlD
Propranolol—CYP3A5—pancreas—stomach cancer	0.000364	0.0145	CbGeAlD
Propranolol—HTR1A—endocrine gland—stomach cancer	0.000349	0.0139	CbGeAlD
Propranolol—CYP3A4—hematopoietic system—stomach cancer	0.000335	0.0134	CbGeAlD
Propranolol—CYP2D6—hematopoietic system—stomach cancer	0.00033	0.0132	CbGeAlD
Propranolol—CYP2C19—endocrine gland—stomach cancer	0.000326	0.013	CbGeAlD
Propranolol—CYP1A2—digestive system—stomach cancer	0.000322	0.0129	CbGeAlD
Propranolol—ORM1—lymph node—stomach cancer	0.000319	0.0127	CbGeAlD
Propranolol—CYP1A1—digestive system—stomach cancer	0.000318	0.0127	CbGeAlD
Propranolol—CYP3A5—digestive system—stomach cancer	0.000311	0.0124	CbGeAlD
Propranolol—CYP2C19—liver—stomach cancer	0.000294	0.0117	CbGeAlD
Propranolol—Practolol—ADRB1—stomach cancer	0.000292	0.0398	CrCbGaD
Propranolol—Levobunolol—ADRB1—stomach cancer	0.000277	0.0377	CrCbGaD
Propranolol—CYP1A2—endocrine gland—stomach cancer	0.000266	0.0106	CbGeAlD
Propranolol—Metipranolol—ADRB1—stomach cancer	0.000264	0.036	CrCbGaD
Propranolol—CYP1A1—endocrine gland—stomach cancer	0.000262	0.0105	CbGeAlD
Propranolol—CYP3A5—endocrine gland—stomach cancer	0.000257	0.0102	CbGeAlD
Propranolol—CYP1A2—liver—stomach cancer	0.00024	0.00957	CbGeAlD
Propranolol—ABCB1—hematopoietic system—stomach cancer	0.000237	0.00947	CbGeAlD
Propranolol—CYP1A1—liver—stomach cancer	0.000237	0.00944	CbGeAlD
Propranolol—Carteolol—ADRB1—stomach cancer	0.000235	0.0321	CrCbGaD
Propranolol—CYP3A4—digestive system—stomach cancer	0.000233	0.0093	CbGeAlD
Propranolol—Levobunolol—ADRB2—stomach cancer	0.000233	0.0317	CrCbGaD
Propranolol—CYP3A5—liver—stomach cancer	0.000231	0.00923	CbGeAlD
Propranolol—CYP2D6—digestive system—stomach cancer	0.000229	0.00915	CbGeAlD
Propranolol—Metipranolol—ADRB2—stomach cancer	0.000222	0.0303	CrCbGaD
Propranolol—ABCB1—epithelium—stomach cancer	0.000217	0.00865	CbGeAlD
Propranolol—Esmolol—ADRB1—stomach cancer	0.00021	0.0286	CrCbGaD
Propranolol—Bevantolol—ADRB1—stomach cancer	0.000207	0.0283	CrCbGaD
Propranolol—Dermatitis exfoliative—Doxorubicin—stomach cancer	0.0002	0.00198	CcSEcCtD
Propranolol—Erythema multiforme—Docetaxel—stomach cancer	0.000198	0.00196	CcSEcCtD
Propranolol—Carteolol—ADRB2—stomach cancer	0.000198	0.027	CrCbGaD
Propranolol—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.000196	0.00194	CcSEcCtD
Propranolol—Purpura—Doxorubicin—stomach cancer	0.000196	0.00194	CcSEcCtD
Propranolol—Visual impairment—Capecitabine—stomach cancer	0.000195	0.00193	CcSEcCtD
Propranolol—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.000195	0.00193	CcSEcCtD
Propranolol—Insomnia—Irinotecan—stomach cancer	0.000195	0.00192	CcSEcCtD
Propranolol—Cardiac disorder—Docetaxel—stomach cancer	0.000194	0.00192	CcSEcCtD
Propranolol—Cardiac arrest—Epirubicin—stomach cancer	0.000194	0.00192	CcSEcCtD
Propranolol—Hypoglycaemia—Doxorubicin—stomach cancer	0.000194	0.00191	CcSEcCtD
Propranolol—Mood swings—Epirubicin—stomach cancer	0.000193	0.00191	CcSEcCtD
Propranolol—Paraesthesia—Irinotecan—stomach cancer	0.000193	0.00191	CcSEcCtD
Propranolol—ABCB1—pancreas—stomach cancer	0.000193	0.00771	CbGeAlD
Propranolol—Lethargy—Doxorubicin—stomach cancer	0.000193	0.0019	CcSEcCtD
Propranolol—CYP3A4—endocrine gland—stomach cancer	0.000193	0.00769	CbGeAlD
Propranolol—Dyspnoea—Irinotecan—stomach cancer	0.000192	0.0019	CcSEcCtD
Propranolol—Bopindolol—ADRB1—stomach cancer	0.000192	0.0262	CrCbGaD
Propranolol—Erythema multiforme—Capecitabine—stomach cancer	0.000192	0.00189	CcSEcCtD
Propranolol—Somnolence—Irinotecan—stomach cancer	0.000191	0.00189	CcSEcCtD
Propranolol—CYP2D6—endocrine gland—stomach cancer	0.00019	0.00756	CbGeAlD
Propranolol—Dyspepsia—Irinotecan—stomach cancer	0.000189	0.00187	CcSEcCtD
Propranolol—Cardiac disorder—Capecitabine—stomach cancer	0.000188	0.00186	CcSEcCtD
Propranolol—Decreased appetite—Irinotecan—stomach cancer	0.000187	0.00185	CcSEcCtD
Propranolol—Insomnia—Fluorouracil—stomach cancer	0.000186	0.00184	CcSEcCtD
Propranolol—Affect lability—Doxorubicin—stomach cancer	0.000186	0.00184	CcSEcCtD
Propranolol—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000186	0.00184	CcSEcCtD
Propranolol—Fatigue—Irinotecan—stomach cancer	0.000185	0.00183	CcSEcCtD
Propranolol—Paraesthesia—Fluorouracil—stomach cancer	0.000185	0.00183	CcSEcCtD
Propranolol—Alopecia—Docetaxel—stomach cancer	0.000185	0.00183	CcSEcCtD
Propranolol—Betaxolol—ADRB1—stomach cancer	0.000185	0.0252	CrCbGaD
Propranolol—Pain—Irinotecan—stomach cancer	0.000184	0.00182	CcSEcCtD
Propranolol—Constipation—Irinotecan—stomach cancer	0.000184	0.00182	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.000184	0.00182	CcSEcCtD
Propranolol—Dyspnoea—Fluorouracil—stomach cancer	0.000184	0.00182	CcSEcCtD
Propranolol—Mental disorder—Docetaxel—stomach cancer	0.000183	0.00181	CcSEcCtD
Propranolol—Somnolence—Fluorouracil—stomach cancer	0.000183	0.00181	CcSEcCtD
Propranolol—Atenolol—ADRB1—stomach cancer	0.000183	0.025	CrCbGaD
Propranolol—Penbutolol—ADRB1—stomach cancer	0.000183	0.025	CrCbGaD
Propranolol—Erythema—Docetaxel—stomach cancer	0.000182	0.0018	CcSEcCtD
Propranolol—CYP1A1—lymph node—stomach cancer	0.000181	0.00724	CbGeAlD
Propranolol—Dyspepsia—Fluorouracil—stomach cancer	0.000181	0.00179	CcSEcCtD
Propranolol—Cardiac arrest—Doxorubicin—stomach cancer	0.00018	0.00177	CcSEcCtD
Propranolol—Decreased appetite—Fluorouracil—stomach cancer	0.000179	0.00177	CcSEcCtD
Propranolol—Alopecia—Capecitabine—stomach cancer	0.000179	0.00177	CcSEcCtD
Propranolol—Mood swings—Doxorubicin—stomach cancer	0.000179	0.00177	CcSEcCtD
Propranolol—Bisoprolol—ADRB1—stomach cancer	0.000178	0.0243	CrCbGaD
Propranolol—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000178	0.00176	CcSEcCtD
Propranolol—Mental disorder—Capecitabine—stomach cancer	0.000178	0.00175	CcSEcCtD
Propranolol—Erythema—Capecitabine—stomach cancer	0.000176	0.00174	CcSEcCtD
Propranolol—Neutropenia—Methotrexate—stomach cancer	0.000176	0.00174	CcSEcCtD
Propranolol—Esmolol—ADRB2—stomach cancer	0.000176	0.0241	CrCbGaD
Propranolol—Pain—Fluorouracil—stomach cancer	0.000176	0.00174	CcSEcCtD
Propranolol—Gastrointestinal pain—Irinotecan—stomach cancer	0.000176	0.00174	CcSEcCtD
Propranolol—Bevantolol—ADRB2—stomach cancer	0.000174	0.0238	CrCbGaD
Propranolol—CYP3A4—liver—stomach cancer	0.000174	0.00693	CbGeAlD
Propranolol—Erectile dysfunction—Methotrexate—stomach cancer	0.000174	0.00172	CcSEcCtD
Propranolol—Bopindolol—HTR1A—stomach cancer	0.000171	0.0234	CrCbGaD
Propranolol—CYP2D6—liver—stomach cancer	0.000171	0.00682	CbGeAlD
Propranolol—Body temperature increased—Irinotecan—stomach cancer	0.00017	0.00168	CcSEcCtD
Propranolol—Abdominal pain—Irinotecan—stomach cancer	0.00017	0.00168	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.00017	0.00168	CcSEcCtD
Propranolol—Bronchitis—Epirubicin—stomach cancer	0.00017	0.00168	CcSEcCtD
Propranolol—Acebutolol—ADRB1—stomach cancer	0.000169	0.023	CrCbGaD
Propranolol—Infestation NOS—Methotrexate—stomach cancer	0.000168	0.00166	CcSEcCtD
Propranolol—Infestation—Methotrexate—stomach cancer	0.000168	0.00166	CcSEcCtD
Propranolol—Depression—Methotrexate—stomach cancer	0.000168	0.00166	CcSEcCtD
Propranolol—Oxprenolol—ADRB1—stomach cancer	0.000168	0.0229	CrCbGaD
Propranolol—ABCB1—lymphoid tissue—stomach cancer	0.000167	0.00667	CbGeAlD
Propranolol—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.000167	0.00165	CcSEcCtD
Propranolol—ABCB1—digestive system—stomach cancer	0.000165	0.00658	CbGeAlD
Propranolol—Neutropenia—Epirubicin—stomach cancer	0.000165	0.00163	CcSEcCtD
Propranolol—Urticaria—Fluorouracil—stomach cancer	0.000164	0.00162	CcSEcCtD
Propranolol—Penbutolol—HTR1A—stomach cancer	0.000164	0.0223	CrCbGaD
Propranolol—Body temperature increased—Fluorouracil—stomach cancer	0.000163	0.00161	CcSEcCtD
Propranolol—Bopindolol—ADRB2—stomach cancer	0.000161	0.022	CrCbGaD
Propranolol—Cough—Docetaxel—stomach cancer	0.000159	0.00157	CcSEcCtD
Propranolol—Vertigo—Capecitabine—stomach cancer	0.000159	0.00157	CcSEcCtD
Propranolol—Hypersensitivity—Irinotecan—stomach cancer	0.000159	0.00157	CcSEcCtD
Propranolol—Convulsion—Docetaxel—stomach cancer	0.000158	0.00156	CcSEcCtD
Propranolol—Infestation—Epirubicin—stomach cancer	0.000157	0.00155	CcSEcCtD
Propranolol—Infestation NOS—Epirubicin—stomach cancer	0.000157	0.00155	CcSEcCtD
Propranolol—Bronchitis—Doxorubicin—stomach cancer	0.000157	0.00155	CcSEcCtD
Propranolol—Agranulocytosis—Methotrexate—stomach cancer	0.000157	0.00155	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000156	0.00154	CcSEcCtD
Propranolol—Betaxolol—ADRB2—stomach cancer	0.000155	0.0212	CrCbGaD
Propranolol—Asthenia—Irinotecan—stomach cancer	0.000154	0.00153	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000154	0.00152	CcSEcCtD
Propranolol—Cough—Capecitabine—stomach cancer	0.000154	0.00152	CcSEcCtD
Propranolol—Atenolol—ADRB2—stomach cancer	0.000154	0.021	CrCbGaD
Propranolol—Penbutolol—ADRB2—stomach cancer	0.000154	0.021	CrCbGaD
Propranolol—Alprenolol—ADRB1—stomach cancer	0.000153	0.0209	CrCbGaD
Propranolol—Neutropenia—Doxorubicin—stomach cancer	0.000153	0.00151	CcSEcCtD
Propranolol—ABCB1—bone marrow—stomach cancer	0.000152	0.00607	CbGeAlD
Propranolol—Hypersensitivity—Fluorouracil—stomach cancer	0.000152	0.0015	CcSEcCtD
Propranolol—Bisoprolol—ADRB2—stomach cancer	0.00015	0.0205	CrCbGaD
Propranolol—Pharyngitis—Methotrexate—stomach cancer	0.00015	0.00148	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000149	0.00147	CcSEcCtD
Propranolol—Anaphylactic shock—Docetaxel—stomach cancer	0.000149	0.00147	CcSEcCtD
Propranolol—Infection—Docetaxel—stomach cancer	0.000148	0.00146	CcSEcCtD
Propranolol—Diarrhoea—Irinotecan—stomach cancer	0.000147	0.00145	CcSEcCtD
Propranolol—Agranulocytosis—Epirubicin—stomach cancer	0.000147	0.00145	CcSEcCtD
Propranolol—Nervous system disorder—Docetaxel—stomach cancer	0.000146	0.00144	CcSEcCtD
Propranolol—Infestation NOS—Doxorubicin—stomach cancer	0.000146	0.00144	CcSEcCtD
Propranolol—Infestation—Doxorubicin—stomach cancer	0.000146	0.00144	CcSEcCtD
Propranolol—Visual impairment—Methotrexate—stomach cancer	0.000145	0.00144	CcSEcCtD
Propranolol—Skin disorder—Docetaxel—stomach cancer	0.000144	0.00143	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000144	0.00143	CcSEcCtD
Propranolol—Bradycardia—Epirubicin—stomach cancer	0.000144	0.00142	CcSEcCtD
Propranolol—Infection—Capecitabine—stomach cancer	0.000143	0.00141	CcSEcCtD
Propranolol—Erythema multiforme—Methotrexate—stomach cancer	0.000143	0.00141	CcSEcCtD
Propranolol—Metoprolol—ADRB1—stomach cancer	0.000142	0.0194	CrCbGaD
Propranolol—Dizziness—Irinotecan—stomach cancer	0.000142	0.00141	CcSEcCtD
Propranolol—Acebutolol—ADRB2—stomach cancer	0.000142	0.0194	CrCbGaD
Propranolol—Carvedilol—VEGFA—stomach cancer	0.000141	0.0193	CrCbGaD
Propranolol—Nervous system disorder—Capecitabine—stomach cancer	0.000141	0.0014	CcSEcCtD
Propranolol—Diarrhoea—Fluorouracil—stomach cancer	0.000141	0.00139	CcSEcCtD
Propranolol—Oxprenolol—ADRB2—stomach cancer	0.000141	0.0192	CrCbGaD
Propranolol—Pharyngitis—Epirubicin—stomach cancer	0.00014	0.00138	CcSEcCtD
Propranolol—Cardiac disorder—Methotrexate—stomach cancer	0.00014	0.00138	CcSEcCtD
Propranolol—Skin disorder—Capecitabine—stomach cancer	0.00014	0.00138	CcSEcCtD
Propranolol—Alprenolol—HTR1A—stomach cancer	0.000137	0.0187	CrCbGaD
Propranolol—Vomiting—Irinotecan—stomach cancer	0.000137	0.00135	CcSEcCtD
Propranolol—ABCB1—endocrine gland—stomach cancer	0.000136	0.00544	CbGeAlD
Propranolol—Dizziness—Fluorouracil—stomach cancer	0.000136	0.00135	CcSEcCtD
Propranolol—Visual impairment—Epirubicin—stomach cancer	0.000136	0.00134	CcSEcCtD
Propranolol—Agranulocytosis—Doxorubicin—stomach cancer	0.000136	0.00134	CcSEcCtD
Propranolol—Rash—Irinotecan—stomach cancer	0.000136	0.00134	CcSEcCtD
Propranolol—Dermatitis—Irinotecan—stomach cancer	0.000136	0.00134	CcSEcCtD
Propranolol—Insomnia—Docetaxel—stomach cancer	0.000135	0.00133	CcSEcCtD
Propranolol—Paraesthesia—Docetaxel—stomach cancer	0.000134	0.00132	CcSEcCtD
Propranolol—Erythema multiforme—Epirubicin—stomach cancer	0.000134	0.00132	CcSEcCtD
Propranolol—Alopecia—Methotrexate—stomach cancer	0.000133	0.00132	CcSEcCtD
Propranolol—Bradycardia—Doxorubicin—stomach cancer	0.000133	0.00131	CcSEcCtD
Propranolol—Dyspnoea—Docetaxel—stomach cancer	0.000133	0.00131	CcSEcCtD
Propranolol—Somnolence—Docetaxel—stomach cancer	0.000132	0.00131	CcSEcCtD
Propranolol—Mental disorder—Methotrexate—stomach cancer	0.000132	0.00131	CcSEcCtD
Propranolol—Pindolol—ADRB1—stomach cancer	0.000132	0.018	CrCbGaD
Propranolol—Erythema—Methotrexate—stomach cancer	0.000131	0.0013	CcSEcCtD
Propranolol—Cardiac disorder—Epirubicin—stomach cancer	0.000131	0.0013	CcSEcCtD
Propranolol—Vomiting—Fluorouracil—stomach cancer	0.000131	0.00129	CcSEcCtD
Propranolol—Dyspepsia—Docetaxel—stomach cancer	0.000131	0.00129	CcSEcCtD
Propranolol—Insomnia—Capecitabine—stomach cancer	0.00013	0.00129	CcSEcCtD
Propranolol—Rash—Fluorouracil—stomach cancer	0.00013	0.00128	CcSEcCtD
Propranolol—Dermatitis—Fluorouracil—stomach cancer	0.00013	0.00128	CcSEcCtD
Propranolol—Pharyngitis—Doxorubicin—stomach cancer	0.00013	0.00128	CcSEcCtD
Propranolol—Paraesthesia—Capecitabine—stomach cancer	0.000129	0.00128	CcSEcCtD
Propranolol—Decreased appetite—Docetaxel—stomach cancer	0.000129	0.00128	CcSEcCtD
Propranolol—Alprenolol—ADRB2—stomach cancer	0.000129	0.0176	CrCbGaD
Propranolol—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000128	0.00127	CcSEcCtD
Propranolol—Dyspnoea—Capecitabine—stomach cancer	0.000128	0.00127	CcSEcCtD
Propranolol—Fatigue—Docetaxel—stomach cancer	0.000128	0.00127	CcSEcCtD
Propranolol—Nausea—Irinotecan—stomach cancer	0.000128	0.00126	CcSEcCtD
Propranolol—Constipation—Docetaxel—stomach cancer	0.000127	0.00126	CcSEcCtD
Propranolol—Pain—Docetaxel—stomach cancer	0.000127	0.00126	CcSEcCtD
Propranolol—Dyspepsia—Capecitabine—stomach cancer	0.000127	0.00125	CcSEcCtD
Propranolol—Visual impairment—Doxorubicin—stomach cancer	0.000126	0.00124	CcSEcCtD
Propranolol—Decreased appetite—Capecitabine—stomach cancer	0.000125	0.00124	CcSEcCtD
Propranolol—Alopecia—Epirubicin—stomach cancer	0.000125	0.00123	CcSEcCtD
Propranolol—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000124	0.00123	CcSEcCtD
Propranolol—Fatigue—Capecitabine—stomach cancer	0.000124	0.00123	CcSEcCtD
Propranolol—Mental disorder—Epirubicin—stomach cancer	0.000124	0.00122	CcSEcCtD
Propranolol—Erythema multiforme—Doxorubicin—stomach cancer	0.000124	0.00122	CcSEcCtD
Propranolol—Pain—Capecitabine—stomach cancer	0.000123	0.00122	CcSEcCtD
Propranolol—Constipation—Capecitabine—stomach cancer	0.000123	0.00122	CcSEcCtD
Propranolol—ABCB1—liver—stomach cancer	0.000123	0.00491	CbGeAlD
Propranolol—Erythema—Epirubicin—stomach cancer	0.000123	0.00121	CcSEcCtD
Propranolol—Nausea—Fluorouracil—stomach cancer	0.000122	0.00121	CcSEcCtD
Propranolol—Gastrointestinal pain—Docetaxel—stomach cancer	0.000122	0.0012	CcSEcCtD
Propranolol—Cardiac disorder—Doxorubicin—stomach cancer	0.000121	0.0012	CcSEcCtD
Propranolol—Metoprolol—ADRB2—stomach cancer	0.00012	0.0164	CrCbGaD
Propranolol—Vertigo—Methotrexate—stomach cancer	0.000118	0.00117	CcSEcCtD
Propranolol—Pindolol—HTR1A—stomach cancer	0.000118	0.0161	CrCbGaD
Propranolol—Gastrointestinal pain—Capecitabine—stomach cancer	0.000118	0.00116	CcSEcCtD
Propranolol—Body temperature increased—Docetaxel—stomach cancer	0.000118	0.00116	CcSEcCtD
Propranolol—Abdominal pain—Docetaxel—stomach cancer	0.000118	0.00116	CcSEcCtD
Propranolol—Alopecia—Doxorubicin—stomach cancer	0.000115	0.00114	CcSEcCtD
Propranolol—Cough—Methotrexate—stomach cancer	0.000115	0.00113	CcSEcCtD
Propranolol—Mental disorder—Doxorubicin—stomach cancer	0.000114	0.00113	CcSEcCtD
Propranolol—Urticaria—Capecitabine—stomach cancer	0.000114	0.00113	CcSEcCtD
Propranolol—Body temperature increased—Capecitabine—stomach cancer	0.000114	0.00112	CcSEcCtD
Propranolol—Abdominal pain—Capecitabine—stomach cancer	0.000114	0.00112	CcSEcCtD
Propranolol—Convulsion—Methotrexate—stomach cancer	0.000114	0.00112	CcSEcCtD
Propranolol—Erythema—Doxorubicin—stomach cancer	0.000114	0.00112	CcSEcCtD
Propranolol—Agitation—Epirubicin—stomach cancer	0.000113	0.00112	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000111	0.0011	CcSEcCtD
Propranolol—Pindolol—ADRB2—stomach cancer	0.000111	0.0151	CrCbGaD
Propranolol—Vertigo—Epirubicin—stomach cancer	0.00011	0.00109	CcSEcCtD
Propranolol—Hypersensitivity—Docetaxel—stomach cancer	0.00011	0.00108	CcSEcCtD
Propranolol—Cough—Epirubicin—stomach cancer	0.000107	0.00106	CcSEcCtD
Propranolol—Anaphylactic shock—Methotrexate—stomach cancer	0.000107	0.00106	CcSEcCtD
Propranolol—Asthenia—Docetaxel—stomach cancer	0.000107	0.00105	CcSEcCtD
Propranolol—Convulsion—Epirubicin—stomach cancer	0.000106	0.00105	CcSEcCtD
Propranolol—Infection—Methotrexate—stomach cancer	0.000106	0.00105	CcSEcCtD
Propranolol—Hypersensitivity—Capecitabine—stomach cancer	0.000106	0.00105	CcSEcCtD
Propranolol—Nervous system disorder—Methotrexate—stomach cancer	0.000105	0.00104	CcSEcCtD
Propranolol—Propafenone—ADRB1—stomach cancer	0.000105	0.0143	CrCbGaD
Propranolol—Agitation—Doxorubicin—stomach cancer	0.000105	0.00103	CcSEcCtD
Propranolol—Skin disorder—Methotrexate—stomach cancer	0.000104	0.00103	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000104	0.00103	CcSEcCtD
Propranolol—Asthenia—Capecitabine—stomach cancer	0.000103	0.00102	CcSEcCtD
Propranolol—Vertigo—Doxorubicin—stomach cancer	0.000102	0.00101	CcSEcCtD
Propranolol—Diarrhoea—Docetaxel—stomach cancer	0.000102	0.00101	CcSEcCtD
Propranolol—Anaphylactic shock—Epirubicin—stomach cancer	0.0001	0.000991	CcSEcCtD
Propranolol—Infection—Epirubicin—stomach cancer	9.97e-05	0.000985	CcSEcCtD
Propranolol—Cough—Doxorubicin—stomach cancer	9.92e-05	0.000981	CcSEcCtD
Propranolol—Convulsion—Doxorubicin—stomach cancer	9.85e-05	0.000974	CcSEcCtD
Propranolol—Diarrhoea—Capecitabine—stomach cancer	9.85e-05	0.000974	CcSEcCtD
Propranolol—Nervous system disorder—Epirubicin—stomach cancer	9.84e-05	0.000972	CcSEcCtD
Propranolol—Dizziness—Docetaxel—stomach cancer	9.83e-05	0.000972	CcSEcCtD
Propranolol—Skin disorder—Epirubicin—stomach cancer	9.74e-05	0.000963	CcSEcCtD
Propranolol—Insomnia—Methotrexate—stomach cancer	9.7e-05	0.000958	CcSEcCtD
Propranolol—Paraesthesia—Methotrexate—stomach cancer	9.63e-05	0.000951	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	9.62e-05	0.00095	CcSEcCtD
Propranolol—Dyspnoea—Methotrexate—stomach cancer	9.56e-05	0.000944	CcSEcCtD
Propranolol—Somnolence—Methotrexate—stomach cancer	9.53e-05	0.000942	CcSEcCtD
Propranolol—Dizziness—Capecitabine—stomach cancer	9.52e-05	0.000941	CcSEcCtD
Propranolol—Vomiting—Docetaxel—stomach cancer	9.46e-05	0.000934	CcSEcCtD
Propranolol—Carvedilol—ADRB1—stomach cancer	9.46e-05	0.0129	CrCbGaD
Propranolol—Dyspepsia—Methotrexate—stomach cancer	9.44e-05	0.000932	CcSEcCtD
Propranolol—ABCB1—lymph node—stomach cancer	9.42e-05	0.00376	CbGeAlD
Propranolol—Rash—Docetaxel—stomach cancer	9.38e-05	0.000927	CcSEcCtD
Propranolol—Dermatitis—Docetaxel—stomach cancer	9.37e-05	0.000926	CcSEcCtD
Propranolol—Decreased appetite—Methotrexate—stomach cancer	9.32e-05	0.000921	CcSEcCtD
Propranolol—Anaphylactic shock—Doxorubicin—stomach cancer	9.28e-05	0.000917	CcSEcCtD
Propranolol—Gastrointestinal disorder—Methotrexate—stomach cancer	9.25e-05	0.000915	CcSEcCtD
Propranolol—Fatigue—Methotrexate—stomach cancer	9.24e-05	0.000913	CcSEcCtD
Propranolol—Infection—Doxorubicin—stomach cancer	9.22e-05	0.000911	CcSEcCtD
Propranolol—Pain—Methotrexate—stomach cancer	9.17e-05	0.000906	CcSEcCtD
Propranolol—Vomiting—Capecitabine—stomach cancer	9.16e-05	0.000905	CcSEcCtD
Propranolol—Nervous system disorder—Doxorubicin—stomach cancer	9.1e-05	0.0009	CcSEcCtD
Propranolol—Rash—Capecitabine—stomach cancer	9.08e-05	0.000897	CcSEcCtD
Propranolol—Insomnia—Epirubicin—stomach cancer	9.07e-05	0.000897	CcSEcCtD
Propranolol—Dermatitis—Capecitabine—stomach cancer	9.07e-05	0.000896	CcSEcCtD
Propranolol—Skin disorder—Doxorubicin—stomach cancer	9.02e-05	0.000891	CcSEcCtD
Propranolol—Paraesthesia—Epirubicin—stomach cancer	9.01e-05	0.00089	CcSEcCtD
Propranolol—Dyspnoea—Epirubicin—stomach cancer	8.94e-05	0.000884	CcSEcCtD
Propranolol—Somnolence—Epirubicin—stomach cancer	8.92e-05	0.000881	CcSEcCtD
Propranolol—Nausea—Docetaxel—stomach cancer	8.83e-05	0.000873	CcSEcCtD
Propranolol—Dyspepsia—Epirubicin—stomach cancer	8.83e-05	0.000873	CcSEcCtD
Propranolol—Gastrointestinal pain—Methotrexate—stomach cancer	8.77e-05	0.000866	CcSEcCtD
Propranolol—Decreased appetite—Epirubicin—stomach cancer	8.72e-05	0.000862	CcSEcCtD
Propranolol—Gastrointestinal disorder—Epirubicin—stomach cancer	8.66e-05	0.000856	CcSEcCtD
Propranolol—Fatigue—Epirubicin—stomach cancer	8.65e-05	0.000855	CcSEcCtD
Propranolol—Constipation—Epirubicin—stomach cancer	8.58e-05	0.000848	CcSEcCtD
Propranolol—Pain—Epirubicin—stomach cancer	8.58e-05	0.000848	CcSEcCtD
Propranolol—Nausea—Capecitabine—stomach cancer	8.55e-05	0.000845	CcSEcCtD
Propranolol—Urticaria—Methotrexate—stomach cancer	8.52e-05	0.000842	CcSEcCtD
Propranolol—Abdominal pain—Methotrexate—stomach cancer	8.47e-05	0.000837	CcSEcCtD
Propranolol—Body temperature increased—Methotrexate—stomach cancer	8.47e-05	0.000837	CcSEcCtD
Propranolol—Insomnia—Doxorubicin—stomach cancer	8.4e-05	0.00083	CcSEcCtD
Propranolol—Paraesthesia—Doxorubicin—stomach cancer	8.33e-05	0.000824	CcSEcCtD
Propranolol—Dyspnoea—Doxorubicin—stomach cancer	8.28e-05	0.000818	CcSEcCtD
Propranolol—Somnolence—Doxorubicin—stomach cancer	8.25e-05	0.000815	CcSEcCtD
Propranolol—Gastrointestinal pain—Epirubicin—stomach cancer	8.2e-05	0.000811	CcSEcCtD
Propranolol—Dyspepsia—Doxorubicin—stomach cancer	8.17e-05	0.000807	CcSEcCtD
Propranolol—Decreased appetite—Doxorubicin—stomach cancer	8.07e-05	0.000797	CcSEcCtD
Propranolol—Gastrointestinal disorder—Doxorubicin—stomach cancer	8.01e-05	0.000792	CcSEcCtD
Propranolol—Fatigue—Doxorubicin—stomach cancer	8e-05	0.000791	CcSEcCtD
Propranolol—Urticaria—Epirubicin—stomach cancer	7.97e-05	0.000788	CcSEcCtD
Propranolol—Carvedilol—ADRB2—stomach cancer	7.95e-05	0.0109	CrCbGaD
Propranolol—Constipation—Doxorubicin—stomach cancer	7.94e-05	0.000784	CcSEcCtD
Propranolol—Pain—Doxorubicin—stomach cancer	7.94e-05	0.000784	CcSEcCtD
Propranolol—Abdominal pain—Epirubicin—stomach cancer	7.93e-05	0.000784	CcSEcCtD
Propranolol—Body temperature increased—Epirubicin—stomach cancer	7.93e-05	0.000784	CcSEcCtD
Propranolol—Hypersensitivity—Methotrexate—stomach cancer	7.9e-05	0.00078	CcSEcCtD
Propranolol—Asthenia—Methotrexate—stomach cancer	7.69e-05	0.00076	CcSEcCtD
Propranolol—Gastrointestinal pain—Doxorubicin—stomach cancer	7.59e-05	0.00075	CcSEcCtD
Propranolol—Hypersensitivity—Epirubicin—stomach cancer	7.39e-05	0.00073	CcSEcCtD
Propranolol—Urticaria—Doxorubicin—stomach cancer	7.37e-05	0.000729	CcSEcCtD
Propranolol—Abdominal pain—Doxorubicin—stomach cancer	7.34e-05	0.000725	CcSEcCtD
Propranolol—Body temperature increased—Doxorubicin—stomach cancer	7.34e-05	0.000725	CcSEcCtD
Propranolol—Diarrhoea—Methotrexate—stomach cancer	7.33e-05	0.000725	CcSEcCtD
Propranolol—Asthenia—Epirubicin—stomach cancer	7.2e-05	0.000711	CcSEcCtD
Propranolol—Dizziness—Methotrexate—stomach cancer	7.09e-05	0.000701	CcSEcCtD
Propranolol—Diarrhoea—Epirubicin—stomach cancer	6.86e-05	0.000678	CcSEcCtD
Propranolol—Hypersensitivity—Doxorubicin—stomach cancer	6.84e-05	0.000676	CcSEcCtD
Propranolol—Vomiting—Methotrexate—stomach cancer	6.82e-05	0.000674	CcSEcCtD
Propranolol—Rash—Methotrexate—stomach cancer	6.76e-05	0.000668	CcSEcCtD
Propranolol—Dermatitis—Methotrexate—stomach cancer	6.75e-05	0.000667	CcSEcCtD
Propranolol—Asthenia—Doxorubicin—stomach cancer	6.66e-05	0.000658	CcSEcCtD
Propranolol—Dizziness—Epirubicin—stomach cancer	6.63e-05	0.000656	CcSEcCtD
Propranolol—Vomiting—Epirubicin—stomach cancer	6.38e-05	0.00063	CcSEcCtD
Propranolol—Nausea—Methotrexate—stomach cancer	6.37e-05	0.000629	CcSEcCtD
Propranolol—Diarrhoea—Doxorubicin—stomach cancer	6.35e-05	0.000628	CcSEcCtD
Propranolol—Rash—Epirubicin—stomach cancer	6.33e-05	0.000625	CcSEcCtD
Propranolol—Dermatitis—Epirubicin—stomach cancer	6.32e-05	0.000624	CcSEcCtD
Propranolol—Dizziness—Doxorubicin—stomach cancer	6.14e-05	0.000607	CcSEcCtD
Propranolol—Nausea—Epirubicin—stomach cancer	5.96e-05	0.000589	CcSEcCtD
Propranolol—Vomiting—Doxorubicin—stomach cancer	5.9e-05	0.000583	CcSEcCtD
Propranolol—Rash—Doxorubicin—stomach cancer	5.85e-05	0.000578	CcSEcCtD
Propranolol—Dermatitis—Doxorubicin—stomach cancer	5.85e-05	0.000578	CcSEcCtD
Propranolol—Nausea—Doxorubicin—stomach cancer	5.51e-05	0.000545	CcSEcCtD
Propranolol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	4.98e-06	8.97e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ERCC2—stomach cancer	4.97e-06	8.96e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—NOS3—stomach cancer	4.97e-06	8.95e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	4.96e-06	8.94e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP2A6—stomach cancer	4.94e-06	8.91e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CD44—stomach cancer	4.91e-06	8.84e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	4.87e-06	8.78e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	4.85e-06	8.74e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AKR1C3—stomach cancer	4.81e-06	8.67e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—VEGFA—stomach cancer	4.8e-06	8.65e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALDOB—stomach cancer	4.77e-06	8.6e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—APC—stomach cancer	4.77e-06	8.59e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PRKCB—stomach cancer	4.76e-06	8.58e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—STAT3—stomach cancer	4.75e-06	8.57e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6ST—stomach cancer	4.74e-06	8.55e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—PIK3CA—stomach cancer	4.73e-06	8.53e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—ALB—stomach cancer	4.71e-06	8.5e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—ALB—stomach cancer	4.71e-06	8.48e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ERCC2—stomach cancer	4.7e-06	8.46e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ENO1—stomach cancer	4.69e-06	8.45e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—MTHFR—stomach cancer	4.67e-06	8.42e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—APC—stomach cancer	4.66e-06	8.4e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—ERBB2—stomach cancer	4.65e-06	8.37e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.61e-06	8.31e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	4.56e-06	8.23e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—APC—stomach cancer	4.56e-06	8.22e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MAPK3—stomach cancer	4.54e-06	8.19e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPP2R1A—stomach cancer	4.54e-06	8.17e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—NOS3—stomach cancer	4.51e-06	8.13e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—NOS3—stomach cancer	4.5e-06	8.11e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	4.46e-06	8.05e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GSTP1—stomach cancer	4.45e-06	8.02e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALOX5—stomach cancer	4.44e-06	8e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPP2R1A—stomach cancer	4.43e-06	7.98e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6R—stomach cancer	4.43e-06	7.97e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MYC—stomach cancer	4.42e-06	7.96e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—MTHFR—stomach cancer	4.42e-06	7.96e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CXCL8—stomach cancer	4.41e-06	7.94e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—HMOX1—stomach cancer	4.39e-06	7.91e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—HRAS—stomach cancer	4.38e-06	7.89e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—MAPK3—stomach cancer	4.37e-06	7.87e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—DPYD—stomach cancer	4.36e-06	7.87e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	4.34e-06	7.83e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GSTP1—stomach cancer	4.34e-06	7.83e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	4.34e-06	7.82e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6R—stomach cancer	4.33e-06	7.8e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MAPK1—stomach cancer	4.32e-06	7.79e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—EGFR—stomach cancer	4.32e-06	7.79e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CAV1—stomach cancer	4.31e-06	7.77e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CDKN1B—stomach cancer	4.3e-06	7.75e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—APOA1—stomach cancer	4.3e-06	7.75e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—HMOX1—stomach cancer	4.28e-06	7.72e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	4.25e-06	7.66e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	4.25e-06	7.65e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6R—stomach cancer	4.23e-06	7.63e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—IL6—stomach cancer	4.19e-06	7.55e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPP2R1A—stomach cancer	4.17e-06	7.52e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CD44—stomach cancer	4.16e-06	7.49e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—MAPK1—stomach cancer	4.15e-06	7.49e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—EGFR—stomach cancer	4.15e-06	7.48e-05	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	4.15e-06	7.48e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	4.14e-06	7.47e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—TYMS—stomach cancer	4.14e-06	7.45e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PTGS2—stomach cancer	4.12e-06	7.43e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PTGS2—stomach cancer	4.12e-06	7.42e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CCND1—stomach cancer	4.11e-06	7.4e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	4.1e-06	7.39e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—JUN—stomach cancer	4.1e-06	7.38e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GSTP1—stomach cancer	4.09e-06	7.37e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GSTM1—stomach cancer	4.09e-06	7.37e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—KRAS—stomach cancer	4.08e-06	7.36e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CAV1—stomach cancer	4.07e-06	7.34e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—APOA1—stomach cancer	4.06e-06	7.32e-05	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	4.06e-06	7.32e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	4.05e-06	7.3e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—TYMS—stomach cancer	4.04e-06	7.27e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—HMOX1—stomach cancer	4.04e-06	7.27e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.03e-06	7.27e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	4.01e-06	7.23e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—RHOA—stomach cancer	4e-06	7.2e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GSTM1—stomach cancer	3.99e-06	7.19e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MMP9—stomach cancer	3.99e-06	7.18e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CDKN1A—stomach cancer	3.97e-06	7.16e-05	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—PIK3CA—stomach cancer	3.97e-06	7.15e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SERPINE1—stomach cancer	3.96e-06	7.14e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NOS3—stomach cancer	3.96e-06	7.13e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—KRAS—stomach cancer	3.92e-06	7.07e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—RHOA—stomach cancer	3.91e-06	7.05e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.89e-06	7.01e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MAPK8—stomach cancer	3.88e-06	6.99e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NOS3—stomach cancer	3.87e-06	6.97e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTT1—stomach cancer	3.86e-06	6.96e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ERCC2—stomach cancer	3.84e-06	6.93e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—RHOA—stomach cancer	3.82e-06	6.89e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2A6—stomach cancer	3.82e-06	6.88e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—TYMS—stomach cancer	3.8e-06	6.86e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PPARG—stomach cancer	3.79e-06	6.83e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NOS3—stomach cancer	3.78e-06	6.82e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	3.77e-06	6.79e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GSTM1—stomach cancer	3.76e-06	6.78e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ERCC2—stomach cancer	3.75e-06	6.76e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PIK3CA—stomach cancer	3.75e-06	6.76e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AKR1C3—stomach cancer	3.71e-06	6.69e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	3.7e-06	6.67e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	3.69e-06	6.64e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TP53—stomach cancer	3.63e-06	6.54e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	3.62e-06	6.52e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ENO1—stomach cancer	3.62e-06	6.52e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—MTHFR—stomach cancer	3.61e-06	6.51e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—PIK3CA—stomach cancer	3.6e-06	6.5e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PPARG—stomach cancer	3.58e-06	6.45e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VEGFA—stomach cancer	3.58e-06	6.45e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—STAT3—stomach cancer	3.54e-06	6.39e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ERBB2—stomach cancer	3.54e-06	6.38e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ERCC2—stomach cancer	3.54e-06	6.37e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPP2R1A—stomach cancer	3.53e-06	6.37e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—MTHFR—stomach cancer	3.53e-06	6.36e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	3.51e-06	6.32e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	3.49e-06	6.28e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—HRAS—stomach cancer	3.47e-06	6.25e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTP1—stomach cancer	3.47e-06	6.25e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	3.43e-06	6.19e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	3.43e-06	6.18e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—HMOX1—stomach cancer	3.42e-06	6.16e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	3.41e-06	6.15e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ALB—stomach cancer	3.41e-06	6.14e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MAPK3—stomach cancer	3.39e-06	6.1e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CXCL8—stomach cancer	3.36e-06	6.05e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	3.35e-06	6.04e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL6—stomach cancer	3.34e-06	6.01e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—HRAS—stomach cancer	3.33e-06	6.01e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CAV1—stomach cancer	3.33e-06	6.01e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—APOA1—stomach cancer	3.33e-06	5.99e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—MTHFR—stomach cancer	3.32e-06	5.99e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL6—stomach cancer	3.32e-06	5.99e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MYC—stomach cancer	3.29e-06	5.93e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CDKN1B—stomach cancer	3.28e-06	5.91e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCND1—stomach cancer	3.27e-06	5.89e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL6—stomach cancer	3.26e-06	5.88e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—JUN—stomach cancer	3.26e-06	5.88e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—NOS3—stomach cancer	3.26e-06	5.87e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CAV1—stomach cancer	3.25e-06	5.86e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—APOA1—stomach cancer	3.25e-06	5.85e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—TYMS—stomach cancer	3.22e-06	5.81e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MAPK1—stomach cancer	3.22e-06	5.81e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EGFR—stomach cancer	3.22e-06	5.8e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ALB—stomach cancer	3.22e-06	5.8e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CD44—stomach cancer	3.21e-06	5.78e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCND1—stomach cancer	3.2e-06	5.76e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL6—stomach cancer	3.19e-06	5.75e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—JUN—stomach cancer	3.19e-06	5.75e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTM1—stomach cancer	3.19e-06	5.74e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.18e-06	5.74e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MMP9—stomach cancer	3.17e-06	5.72e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	3.16e-06	5.7e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCND1—stomach cancer	3.13e-06	5.64e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—JUN—stomach cancer	3.12e-06	5.62e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MMP9—stomach cancer	3.1e-06	5.6e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	3.09e-06	5.58e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	3.09e-06	5.56e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—NOS3—stomach cancer	3.08e-06	5.55e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CAV1—stomach cancer	3.07e-06	5.52e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOA1—stomach cancer	3.06e-06	5.51e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—KRAS—stomach cancer	3.04e-06	5.48e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MMP9—stomach cancer	3.04e-06	5.47e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CDKN1A—stomach cancer	3.03e-06	5.45e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	3.02e-06	5.44e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ERCC2—stomach cancer	2.99e-06	5.4e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTGS2—stomach cancer	2.98e-06	5.37e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MAPK8—stomach cancer	2.95e-06	5.32e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPARG—stomach cancer	2.93e-06	5.28e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPARG—stomach cancer	2.86e-06	5.15e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	2.85e-06	5.14e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—STAT3—stomach cancer	2.82e-06	5.09e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTGS2—stomach cancer	2.82e-06	5.08e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—MTHFR—stomach cancer	2.82e-06	5.07e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PIK3CA—stomach cancer	2.8e-06	5.04e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	2.79e-06	5.02e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—STAT3—stomach cancer	2.76e-06	4.98e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPP2R1A—stomach cancer	2.73e-06	4.92e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VEGFA—stomach cancer	2.73e-06	4.91e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TP53—stomach cancer	2.7e-06	4.87e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—STAT3—stomach cancer	2.7e-06	4.86e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	2.7e-06	4.86e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPARG—stomach cancer	2.69e-06	4.86e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTP1—stomach cancer	2.68e-06	4.82e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HMOX1—stomach cancer	2.64e-06	4.75e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	2.64e-06	4.75e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ALB—stomach cancer	2.63e-06	4.75e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MYC—stomach cancer	2.62e-06	4.73e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CAV1—stomach cancer	2.6e-06	4.68e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOA1—stomach cancer	2.59e-06	4.67e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—HRAS—stomach cancer	2.59e-06	4.66e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MAPK3—stomach cancer	2.58e-06	4.65e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ALB—stomach cancer	2.57e-06	4.63e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	2.57e-06	4.62e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MYC—stomach cancer	2.57e-06	4.62e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EGFR—stomach cancer	2.56e-06	4.62e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PIK3CA—stomach cancer	2.54e-06	4.57e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PIK3CA—stomach cancer	2.53e-06	4.57e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—NOS3—stomach cancer	2.52e-06	4.54e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	2.51e-06	4.52e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EGFR—stomach cancer	2.51e-06	4.52e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MYC—stomach cancer	2.51e-06	4.52e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—TYMS—stomach cancer	2.49e-06	4.48e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.48e-06	4.47e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL6—stomach cancer	2.48e-06	4.46e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—NOS3—stomach cancer	2.46e-06	4.43e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTM1—stomach cancer	2.46e-06	4.43e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MAPK1—stomach cancer	2.45e-06	4.42e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EGFR—stomach cancer	2.45e-06	4.42e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—KRAS—stomach cancer	2.42e-06	4.37e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ALB—stomach cancer	2.42e-06	4.37e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—KRAS—stomach cancer	2.37e-06	4.27e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—NOS3—stomach cancer	2.32e-06	4.18e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—KRAS—stomach cancer	2.32e-06	4.18e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ERCC2—stomach cancer	2.31e-06	4.17e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTGS2—stomach cancer	2.3e-06	4.15e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPARG—stomach cancer	2.28e-06	4.11e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTGS2—stomach cancer	2.25e-06	4.05e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	2.23e-06	4.01e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	2.18e-06	3.92e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—MTHFR—stomach cancer	2.17e-06	3.92e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TP53—stomach cancer	2.15e-06	3.88e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CA—stomach cancer	2.13e-06	3.84e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTGS2—stomach cancer	2.12e-06	3.82e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TP53—stomach cancer	2.11e-06	3.8e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TP53—stomach cancer	2.06e-06	3.71e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HRAS—stomach cancer	2.06e-06	3.71e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ALB—stomach cancer	2.05e-06	3.7e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HRAS—stomach cancer	2.01e-06	3.63e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CAV1—stomach cancer	2e-06	3.61e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOA1—stomach cancer	2e-06	3.6e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6—stomach cancer	1.97e-06	3.55e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HRAS—stomach cancer	1.97e-06	3.55e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NOS3—stomach cancer	1.96e-06	3.54e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6—stomach cancer	1.93e-06	3.48e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6—stomach cancer	1.89e-06	3.4e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CA—stomach cancer	1.83e-06	3.31e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTGS2—stomach cancer	1.8e-06	3.24e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPARG—stomach cancer	1.76e-06	3.18e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CA—stomach cancer	1.73e-06	3.12e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALB—stomach cancer	1.58e-06	2.85e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NOS3—stomach cancer	1.52e-06	2.73e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.42e-06	2.56e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTGS2—stomach cancer	1.39e-06	2.5e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CA—stomach cancer	1.38e-06	2.49e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.3e-06	2.35e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.1e-06	1.99e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CA—stomach cancer	8.53e-07	1.54e-05	CbGpPWpGaD
